Effect of sunitinib on metastatic gastrointestinal stromal tumor in patients with neurofibromatosis type 1: A case report

World Journal of Gastroenterology

Volumn 13, Issue 18, 2007, Pages 2629-2632

  Kalender, M Emin ^a   Sevinc, Alper ^a   Tutar, Ediz ^a   Sirikci, Akif ^a   Camci, Celalettin ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Gastrointestinal stromal tumors; Imatinib; Neurofibromatosis; Sunitinib

Indexed keywords

ACTIN; IMATINIB; STEM CELL FACTOR RECEPTOR; SUNITINIB; VIMENTIN;

ABDOMINAL MASS; ADULT; ARTICLE; CANCER GROWTH; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG MEGADOSE; ECHOGRAPHY; ESOPHAGOGASTRODUODENOSCOPY; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LIVER METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEUM; PERITONEUM METASTASIS; TUMOR VOLUME;

EID: 34250635103     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i18.2629     Document Type: Article

References (19)

1. Kindblom LG, Meis-Kindblo J, Bümming P, et al. Incidence, prevalence, phenotype and biologic spectrum of gastrointestinal stromal cell tumors (GIST)- a population based study of 600 cases (abstract 577O). Ann Oncol 2002;13 Suppl 5: 157
2. Sinha R, Verma R, Kong A. Mesenteric gastrointestinal stromal tumor in a patient with neurofibromatosis. AJR Am J Roentgenol 2004; 183: 1844-1846
3. Koppen S, Wejda B, Dormann A, Hoffmeister D, Stolte M, Huchzermeyer H. Gastrointestinal stromal tumours (GIST) of the jejunum in a patient with neurofibromatosis type 1 (von Recklingshausen's disease). Z Gastroenterol 2004; 42: 1183-1187
4. Nakamura H, Satoh Y, Ikeda T, Endoh T, Imai K. A case of upper jejunal gastrointestinal stromal tumor (GIST) accompanied with von Recklinghausen's disease. Nippon Shokakibyo Gakkai Zasshi 2000; 97: 1385-1390
5. Perez-Atayde AR, Shamberger RC, Kozakewich HW. Neuroectodermal differentiation of the gastrointestinal tumors in the Carney triad. An ultrastructural and immunohistochemical study. Am J Surg Pathol 1993; 17: 706-714
6. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CL Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299: 708-710
7. Arun D, Gutmann DH. Recent advances in neurofibromatosis type 1. Curr Opin Neurol 2004; 17: 101-105
8. Lee JH, David M. Cancers of Childhood. Cancer Principles & Practice of Oncology. 7th ed. 1889-1897
9. Fuller CE, Williams GT. Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology 1991; 19: 1-11
10. Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, Sobin LH, Lasota J. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003; 27: 625-641
11. Min KW, Balaton AJ. Small intestinal stromal tumors with skeinoid fibers in neurofibromatosis: report of four cases with ultrastructural study of skeinoid fibers from paraffin blocks. Ultrastruct Pathol 1993; 17: 307-314
12. Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 2006; 30: 90-96
13. Bagnolo F, Bonassi U, Scelsi R, Testoni PA. Gastric stromal tumour: a rare neoplasm presenting with gastrointestinal bleeding. Eur J Gastroenterol Hepatol 1998; 10: 791-794
14. Pidhorecky I, Cheney RT, Kraybill WG, Gibbs JF. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000; 7: 705-712
15. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-1220
16. Levy AD, Patel N, Abbott RM, Dow N, Miettinen M, Sobin LH. Gastrointestinal stromal tumors in patients with neurofibromatosis: imaging features with clinicopathologic correlation. AJR Am J Roentgenol 2004; 183: 1629-1636
17. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002; 347: 472-480
18. Heinrich MC, Maki RG, Corless CL, Antonescu CR, Fletcher JA, Fletcher CD, Huang X, Baum CM, Demetri GD. Sunitinib (SU) response in imatinib-resistant (IM-R) GIST correlates with KIT and PDGFRA mutation status (abstract 9502). J Clin Oncol 2006; 24 suppl: 520
19. Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, Baum CM, Casali PG. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 2006; 368: 1329-1338